Asia Pac ECM and Index Rebal, Shenton Research

Ke Yan, CFA, FRM

Asia Pac ECM and Index Rebal

Asia Pac IPO & Placement Research, China Biotech

DZT Research

DZT Research is an independent Asia Pacific equity specialist. Our quantitative research covers index rebalancing flows, alongside exchange data analytics accross Asia Pacific. On the equity capital markets side, we focus on Asia Pacific ECM, especially biotech and TMT. Our lead analyst is frequently cited by international media.

Equity Capital Markets

AOBiome Therapeutics / Equity Capital Markets

AOBiome Therapeutics, a U.S. based biotech company, is planning to raise up to USD 200 million in its listing on the Hong Kong Stock Exchange.
In this insight, we will look at the following topics:
<ul>
<li>Mechanism of the AOB. </li>
<li>The licensing agreement with MBX.</li>
<li>The company's pipeline indications and comparison with current therapies.</li>
<li>The addressable market for the company.</li>
<li>The company's history, investors and management.</li>
</ul>
We will discuss the company's valuation in our next insight.

AOBiome Therapeutics, a U.S. based biotech company, is planning to raise up to USD 200 million in its listing on the Hong Kong Stock Exchange.
In this insight, we will look at the following topics:

Mechanism of the AOB. 
The licensing agreement with MBX.
The company's pipeline indications and comparison with current therapies.
The addressable market for the company.
The company's history, investors and management.

We will discuss the company's valuation in our next insight.

AOBiome Therapeutics IPO: Hope for Natural Therapeutic Treatment

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

AOBiome Therapeutics (AOB HK)

AOBiome Therapeutics IPO: Hope for Natural Therapeutic Treatment

AOBiome Therapeutics, a U.S. based biotech company, is planning to raise up to USD 200 million in its listing on the Hong Kong Stock Exchange. In...

Ke Yan, CFA, FRM

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)